124 related articles for article (PubMed ID: 8220147)
41. Successful treatment of both double minute of C-MYC and BCL-2 rearrangement containing large B-cell lymphoma with subsequent unfortunate development of therapy-related acute myeloid leukemia with t(3;3)(q26.2;q21).
Nguyen JC; Kubik MJ; Broome HE; Curtin PT; Dell'Aquila ML; Wang HY
Pathol Res Pract; 2015 Nov; 211(11):883-91. PubMed ID: 26300063
[TBL] [Abstract][Full Text] [Related]
42. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
43. Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review.
Chen W; Wang E; Lu Y; Gaal KK; Huang Q
Am J Clin Pathol; 2010 Jan; 133(1):75-82. PubMed ID: 20023261
[TBL] [Abstract][Full Text] [Related]
44. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
[TBL] [Abstract][Full Text] [Related]
45. Secondary chronic myelomonocytic leukemia with t(9;11) in a child.
George R; Pearson AD; Evans J; Reid MM
Cancer Genet Cytogenet; 1994 Jul; 75(1):64-6. PubMed ID: 8039167
[TBL] [Abstract][Full Text] [Related]
46. Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus.
Stanulla M; Wang J; Chervinsky DS; Aplan PD
Leukemia; 1997 Apr; 11(4):490-6. PubMed ID: 9096688
[TBL] [Abstract][Full Text] [Related]
47. Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina.
Felice MS; Zubizarreta PA; Chantada GL; Alfaro E; Cygler AM; Gallego M; Rossi J; Sackmann-Muriel F
Med Pediatr Oncol; 1998 Mar; 30(3):160-4. PubMed ID: 9434824
[TBL] [Abstract][Full Text] [Related]
48. Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomes.
Menghrajani K; Zhang Y; Famulare C; Devlin SM; Tallman MS
Leuk Res; 2020 Nov; 98():106453. PubMed ID: 33059120
[TBL] [Abstract][Full Text] [Related]
49. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
[TBL] [Abstract][Full Text] [Related]
50. [Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
Saito M; Mori A; Irie T; Tanaka M; Morioka M
Rinsho Ketsueki; 2009 Mar; 50(3):192-6. PubMed ID: 19352087
[TBL] [Abstract][Full Text] [Related]
51. Acute lymphoblastic leukaemia following Hodgkin's disease is associated with a good prognosis.
Narayanan MN; Morgenstern GR; Chang JC; Harrison CJ; Ranson M; Scarffe JH
Br J Haematol; 1994 Apr; 86(4):867-9. PubMed ID: 7918085
[TBL] [Abstract][Full Text] [Related]
52. Transient therapy-related myelodysplastic syndrome associated with monosomy 7 and 11q23 translocation.
Laver JH; Yusuf U; Cantu ES; Barredo JC; Holt LB; Abboud MR
Leukemia; 1997 Mar; 11(3):448-50. PubMed ID: 9067588
[TBL] [Abstract][Full Text] [Related]
53. Acute myeloid leukemia with t(11;19)(q23;p13) developing in an adult T-cell leukemia patient treated with combined chemotherapy including etoposide.
Kanemura N; Tsurumi H; Hara T; Yamada T; Sawada M; Naito T; Moriwaki H
Int J Hematol; 2001 Dec; 74(4):475-6. PubMed ID: 11794709
[No Abstract] [Full Text] [Related]
54. Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents.
Cowell IG; Austin CA
Int J Environ Res Public Health; 2012 Jun; 9(6):2075-91. PubMed ID: 22829791
[TBL] [Abstract][Full Text] [Related]
55. Acute leukemia presenting a variant Ph chromosome with p190 expression, dup 3q and -7, developed after malignant lymphoma treated with alkylating agents and topoisomerase II inhibitors.
Alimena G; Cedrone M; Nanni M; De Cuia MR; Lo Coco F; De Sanctis V; Cimino G; Mancini M
Leukemia; 1995 Sep; 9(9):1483-6. PubMed ID: 7658716
[TBL] [Abstract][Full Text] [Related]
56. Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.
Pedersen-Bjergaard J; Philip P
Blood; 1991 Aug; 78(4):1147-8. PubMed ID: 1651134
[No Abstract] [Full Text] [Related]
57. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
Felix CA; Winick NJ; Negrini M; Bowman WP; Croce CM; Lange BJ
Cancer Res; 1993 Jul; 53(13):2954-6. PubMed ID: 8319201
[TBL] [Abstract][Full Text] [Related]
58. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature.
Quesnel B; Kantarjian H; Bjergaard JP; Brault P; Estey E; Lai JL; Tilly H; Stoppa AM; Archimbaud E; Harousseau JL
J Clin Oncol; 1993 Dec; 11(12):2370-9. PubMed ID: 8246025
[TBL] [Abstract][Full Text] [Related]
59. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
60. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
